节点文献

三维适形放疗联合肝动脉化疗栓塞治疗原发性肝癌伴门静脉癌栓的疗效分析

Pilot study on combined three-dimensional conformal radotherapy and transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 房彤封国生刘丽孙保锦陈力高宏

【Author】 FANG Tong, FENG Guo-sheng,Liu Li,et al. Departement of Radiation Oncology,Beijing Shijitan Hospital. Beijing 100038, China;

【机构】 北京世纪坛医院肿瘤中心北京世纪坛医院肿瘤中心内蒙古医学院附属人民医院

【摘要】 目的观察三维适形放疗联合TACE对不能手术的原发性肝癌伴门静脉癌栓的临床疗效。方法33例原发性肝癌合并门静脉癌栓患者,TACE1~2次后,行三维适形放射治疗,大体肿瘤靶区只包括癌栓,不包括肝内原发灶,采用4~6个共面或非共面照射野,使90%的等剂量曲线覆盖PTV。照射总量45~60Gy,单次照射剂量2~4Gy/次。结果有效率(CR+PR)为54·6%(18/33),1、2年的生存率分别为45·5%和21·2%。无严重并发症出现。结论三维适形放射治疗联合TACE对肝癌合并门静脉癌栓有较好的疗效。

【Abstract】 Objective To study clinical therapeutic effctiveness of combined 3-dimensional conformal radiotherapy(3DCRT)and transcatheter arterial chemoembolization for portal vein tumor thrombus(PVTT)in unresectable hepatocellular carcinoma(HCC). Methods 33 patients with unresectable hepatocellular carcinoma complicated with tumor thrombus in the portal vein were enroled in this study. RT was started 1-2 fractions following TACE. A total dose of 45-60 Gy was given as daily 2-4 Gy fractions, with the gross tumor volume(GTV) defined as only PVTT, 90% isodose line covering PTV. Results The effective rate was 54.6%. Survival rates at year 1 and 2 were 45.5% and 21.2%, respectively. Conclusions 3DCRT combined with TACE is an effective method in the treatment of portal vein tumor thrombus in unresectable hepatocellular carcinoma.;

  • 【文献出处】 中华放射医学与防护杂志 ,Chinese Journal of Radiological Medicine and Protection , 编辑部邮箱 ,2006年05期
  • 【分类号】R735.7
  • 【被引频次】3
  • 【下载频次】158
节点文献中: 

本文链接的文献网络图示:

本文的引文网络